Simon Kiddle

Simon Kiddle
Simon is a member of the life sciences patent team and has considerable experience in the pharmaceutical and biotechnology sectors as well as the nanotech and Cleantech sectors. He has worked on many top selling biologics having prosecuted patent applications, run oppositions and appeals, and provided due diligence work in relation to Nutropin AQ®, Herceptin® and Lyxumia® (lixisenatide).

Find me on:

Recent Posts

Is your interest legitimate? New referral to the EBOA on double patenting

Simon Kiddle

Simon Kiddle
22 Feb 2019

EPO Board of Appeal 3.3.01 is referring a number of questions regarding double patenting to the Enlarged Board of Appeal.  The answers may force.